Kangmei Pharmaceutical Co., Ltd.

Overview

Kangmei Pharmaceutical Co., Ltd. is a leading Chinese pharmaceutical company that specializes in the production and distribution of traditional Chinese medicine (TCM) products. Founded in 1997, the company is committed to the research and development of innovative TCM solutions for a global market.

Therapeutic areas

API / Drug Master Files

Kangmei Pharmaceutical Co., Ltd. holds 17 active (23 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• CALCIUM LACTATE PENTAHYDRATEActive2026-02-05
• SODIUM ACETATE TRIHYDRATEActive2025-09-30
• CALCIUM ACETATEActive2025-09-28
• OSELTAMIVIR PHOSPHATEActive2025-08-22
• OSELTAMIVIR EPOXIDEActive2025-08-18
• EFINACONAZOLE\KActive2022-12-02
• SODIUM LACTATE SOLUTIONActive2020-09-26
• TETRACYCLINE HYDROCHLORIDEActive2019-01-14
• KP-470Active2018-05-30
• SOFPIRONIUM BROMIDEActive2017-09-22
• EFINACONAZOLEActive2013-05-24
• LINCOMYCIN HYDROCHLORIDEActive2012-11-02
• KP-103/BActive2008-07-25
• CLINDAMYCIN HYDROCHLORIDEActive2007-10-25
• CHLORTETRACYCLINE HYDROCHLORIDEActive1998-09-01

Showing 15 of 23 Drug Master Files.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Kangmei Pharmaceutical Co., Ltd. in our records. PharmaTek screens the full directory against live FDA enforcement data.